At the 2024 Telstra Best of Business Awards in February, Earworx was recognised as the National Championing Health Award winner. Lisa Hellwege, the Clinical Director and Founder of Earworx, expressed her gratitude to the entire team and their patients for their trust and support. Earworx specialises in providing professional earwax removal services led by trained nurses using a procedure called microsuction.
Having identified a gap in the market for safe and gentle earwax removal services in her local community, Lisa started Earworx as a part-time venture alongside her role at the Royal Hobart Hospital. Over time, the business grew, and she transitioned to running it full-time, overcoming various challenges along the way, including the impact of COVID-19 and navigating the regulatory environment.
The recognition received at the Telstra Best of Business Award was a meaningful validation of Earworx’s efforts. It not only bolstered the business’s already strong reputation but also provided a boost to its branding, according to Hellwege.
Describing the rigorous application process, including extensive submissions and nerve-wracking presentations, Hellwege acknowledged that it provided invaluable insights into their own business.
Looking ahead, Earworx aims to raise awareness about the vital role of registered nurses in supporting the Australian healthcare system and addressing its challenges. The business plans to continue its mission of delivering high-quality, nurse-led earwax removal services while advocating for recognition and support from funding bodies.
-
Challenge advances health technologies and medical devices in the MedTech sector
In July IDE Group launched the 2027 Building Better Futures for Health (BBFH) Challenge, a program supporting early-stage MedTech innovators move from concept to commercialisation. Delivered with Medical Technology Association of Australia’s (MTAA) MedTech Compass, the 2027 program marks 10 years of impact.
Now in its 11th year, BBFH supports researchers, clinicians, entrepreneurs and early-stage ventures tackling urgent healthcare needs. Selected teams will pitch to industry experts, gaining feedback to strengthen commercial potential.
-
Gaining a better understanding of perimenopause and menopause
Nearly half of women seeking help for menopause symptoms are already experiencing clinically significant distress by the time they ask for support, according to a recent national benchmark report released by Metluma.
The 2026 Australian Menopause Experience Report, based on insights from 1,468 women using Metluma’s UMA40 assessment tool, found 43% triggered at least one clinical red flag at baseline (referral to a doctor within 24-48 hours), with more than one in five presenting with multiple red flags linked to more complex symptom burden.
-
Greater flexibility in medicine safety programs delivered by pharmacists
Addressing delegates at PSA26, the Pharmaceutical Society of Australia’s (PSA) yearly conference, the Minister for Health and Ageing, the Hon. Mark Butler MP, announced negotiations are progressing on the First Pharmacy Programs Agreement (1PPA), and that from 1 November, follow-up services for Home Medicines Reviews (HMRs) and Residential Medication Management Reviews (RMMRs) programs will be able to be delivered via telehealth.
